Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CARA stock: Cara Therapeutics Inc

Current Rating
Strong Buy

Previous Rating

Strong Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$28.31
Market Cap
1.08B
Sector
Health Care
Div. Growth
-
P/E
659.5
P/B
4.3
P/S
7.93
Dividend %
-
P/CF
59.4
P/FCF
-
Op. Cash Flow
-5.5K
FCF
-
Op. Margin
4.00%
Net Margin
6.20%
ROE
5.00%
ROI
2.40%
ROA
4.30%
EPS Growth
103.90%
Current Ratio
10.5
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Eyenovia Inc (EYEN) $5.38 - - 127.6M Strong Buy
Teva Pharmaceutical Industries (TEVA) $10.75 - - 12.5B Strong Buy
RadNet Inc. (RDNT) $22.22 - - 1.14B Strong Buy
Regulus Therapeutics Inc (RGLS) $1.29 - - 113.1M Strong Buy
Cumberland Pharmaceuticals, In (CPIX) $3.04 - - 45.2M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More